Provisioning Coverage Ratio (PCR)

The Provisioning Coverage Ratio (PCR) is a prudential banking metric that quantifies the extent to which a bank has set aside reserves against the loans it has classified as non-performing. Its conceptual foundation lies in the income-recognition, asset-classification and provisioning (IRAC) norms issued by the Reserve Bank of India (RBI) under the Banking Regulation Act, 1949, and refined through successive master circulars. Provisioning itself is rooted in the conservatism principle of accounting and in the Basel framework's expectation that banks recognise expected and incurred credit losses before they crystallise. The IRAC norms prescribe graduated provisioning percentages — for instance, sub-standard, doubtful and loss assets attract escalating rates — and the PCR aggregates these provisions into a single coverage figure expressed as a percentage of gross non-performing assets (NPAs). The ratio gained explicit regulatory prominence when the RBI, in its second-quarter monetary policy review of October 2009, directed banks to achieve a minimum PCR of 70 per cent by September 2010, treating it as a buffer against systemic stress that had surfaced after the 2008 global financial crisis.

The mechanics of computing PCR begin with the bank classifying its advances into standard and non-performing categories at each reporting date. An account becomes an NPA when interest or principal remains overdue for more than 90 days, per the IRAC norms. Against each NPA category the bank computes the prescribed provision — 15 per cent for secured sub-standard assets, higher rates for doubtful assets graduated by the period of default, and 100 per cent for loss assets and the unsecured portions of doubtful exposures. The numerator of the PCR is the sum of all such provisions held, frequently inclusive of technical or prudential write-offs and floating provisions. The denominator is the gross NPA figure. Dividing the former by the latter and multiplying by one hundred yields the ratio. A PCR of 70 per cent therefore signals that the bank has provided for seventy paise of every rupee of bad loans on its books, leaving only thirty paise as unprovided exposure that could erode capital if the loan is ultimately written off.

A methodological distinction matters in interpretation. The RBI has historically referenced PCR computed both with and without including technical write-offs, sometimes labelling the inclusive figure the PCR including write-offs (PCRTWO). Banks also maintain a Counter-Cyclical Provisioning Buffer or floating provisions, which the RBI permitted to be reckoned within the coverage. When PCR exceeded the regulatory floor, the surplus over the prescribed IRAC provisioning was at one stage allowed to be transferred to a separate "counter-cyclical provisioning buffer" account, drawable in periods of stress with RBI approval. This design embeds a macroprudential logic: build reserves in good years and release them in downturns, dampening the procyclicality of credit losses. The ratio is reported in banks' annual financial statements and in the RBI's biannual Financial Stability Report, which tracks the aggregate PCR of scheduled commercial banks.

Contemporary movements in PCR illustrate its diagnostic value. Following the RBI's Asset Quality Review initiated in 2015 under Governor Raghuram Rajan, Indian banks were compelled to recognise concealed stressed assets, sharply raising gross NPAs and forcing a rebuilding of provisions. The Financial Stability Reports of subsequent years recorded the aggregate PCR of scheduled commercial banks rising from around 44 per cent in 2015 to above 70 per cent by 2021 and exceeding 75 per cent by 2023, reflecting both aggressive provisioning and recoveries through the Insolvency and Bankruptcy Code, 2016. Public-sector banks such as the State Bank of India and Punjab National Bank reported individual PCRs surpassing 90 per cent in their post-2020 annual results, a marker of balance-sheet repair that the Ministry of Finance cited in defending its bank recapitalisation programme.

PCR must be distinguished from adjacent metrics with which it is frequently conflated. It differs from the Capital to Risk-Weighted Assets Ratio (CRAR), which measures total regulatory capital against risk-weighted exposures and addresses solvency broadly, whereas PCR is confined to the adequacy of cushioning against already-soured loans. It is also distinct from the Gross NPA ratio and Net NPA ratio: the Net NPA ratio is in fact the residual after provisions are deducted, so a higher PCR mechanically lowers net NPAs. PCR likewise differs from the Loan Loss Reserve coverage discussed in international supervisory literature, and from the forward-looking Expected Credit Loss models under IFRS 9, which the RBI is moving Indian banks toward adopting in a phased manner.

Controversies attend the ratio's use. Critics note that PCR can be inflated by aggressive write-offs that remove NPAs from the denominator without genuine recovery, flattering the headline coverage. The interplay between PCR targets and reported profitability also generates tension, since higher provisioning depresses near-term earnings — a concern the RBI weighed when it relaxed the rigid 70 per cent floor in April 2011, converting it into a bank-specific guidance rather than a uniform mandate. The pending transition to an Expected Credit Loss regime, signalled by the RBI's discussion paper of January 2023, will further reshape how coverage is computed, shifting from rule-based percentages toward model-driven estimates of lifetime losses.

For the working practitioner — a UPSC General Studies Paper III aspirant, a banking-desk journalist or a finance-ministry officer — the PCR is a compact indicator of the resilience and credibility of a bank's balance sheet. Reading it alongside CRAR, the Gross and Net NPA ratios and slippage trends permits a rounded assessment of asset quality. A rising sector-wide PCR, as documented in recent Financial Stability Reports, signals that banks are better insulated against fresh shocks, while a divergence between PCR including and excluding write-offs warns of cosmetic improvement masking weaker recovery performance.